Objectives: The safety and performance of the Otologics fully implantable hearing device were assessed in adult patients with mixed conductive and sensorineural hearing loss. Methods: The subcutaneous microphone of this fully implantable device picks up ambient sounds, converts them into an electrical signal, amplifies the signal according to the user’s needs, and sends it to an electromechanical transducer. The transducer tip is customized with a prosthesis in order to be in contact with the round window membrane and is protected by fascia; this translates the electrical signal into a mechanical motion that directly stimulates the round window membrane and enables the user to perceive sound. The implanted battery is recharged daily via an external charger and the user can turn the implant on and off as well as adjust the volume with a hand-held remote control. In this pilot study, 6 patients with mixed conductive and sensorineural hearing loss were implanted with the Otologics fully implantable hearing device. Pre- and postoperative air conduction, bone conduction, as well as aided and unaided thresholds and speech scores were measured. Results: No significant differences between preoperative and postoperative pure-tone averages were noted. Average improvement ranged from 19.16 to 35.8 dB of functional gain across audiometric frequencies with a mean of 26.17 ± 5.15 dB. Long-term average functional gain at 12 months was 20.83 ± 6.22 dB. Word recognition scores demonstrated significant differences between unaided and implant-aided conditions. Conclusions: Preliminary results of this trial of the Otologics fully implantable hearing device provide evidence that this fully implantable device is capable of efficiently transferring the sound to the inner ear via the round window membrane in patients with mixed hearing loss.

1.
Colletti V, Soli SD, Carner M, Colletti L: Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol 2006;45:600–608.
2.
Cox RM, Alexander GC: The abbreviated profile of hearing aid benefit. Ear Hear 1995;16:176–186.
3.
Dumon T, Zennaro O, Aran JM, Bebear JP: Piezoelectric middle ear implant preserving the ossicular chain. Otolaryngol Clin North Am 1995;28:173–187.
4.
Fisch U, Cremers CW, Lenarz T, Weber B, Babighian G, Uziel AS, Proops DW, O’Connor AF, Charachon R, Helms J, Fraysse B: Clinical experience with the Vibrant Soundbridge implant device. Otol Neurotol 2001;22:962–972.
5.
Jenkins HA, Niparko JK, Slattery WH, Neely JG, Fredrickson JM: Otologics Middle Ear Transducer Ossicular Stimulator: performance results with varying degrees of sensorineural hearing loss. Acta Otolaryngol 2004;124:391–394.
6.
Kasic JF, Fredrickson JM: The Otologics MET ossicular stimulator. Otolaryngol Clin North Am 2001;34:501–513.
7.
Ko WH, Zhu WL, Maniglia AJ: Engineering principles of mechanical stimulation of the middle ear. Otolaryngol Clin North Am 1995;28:29–41.
8.
Maniglia AJ, Ko WH, Garverick SL, Abbass H, Kane M, Rosenbaum M, Murray G: Semi-implantable middle ear electromagnetic hearing device for sensorineural hearing loss. Ear Nose Throat J 1997;76:333–338, 340–341.
9.
Martin C, Tringali S, Bertholon P, Pouget JF, Prades JM: Isolated congenital round window absence. Ann Otol Rhinol Laryngol 2002;111:799–801.
10.
Siegert R, Mattheis S, Kasic J: Fully implantable hearing aids in patients with congenital auricular atresia. Laryngoscope 2007;117:336–340.
11.
Snik AF, Mylanus EA, Cremers CW, Dillier N, Fisch U, Gnadeberg D, Lenarz T, Mazolli M, Babighian G, Uziel AS, Cooper HR, O’Connor AF, Fraysse B, Charachon R, Shehata-Dieler WE: Multicenter audiometric results with the Vibrant Soundbridge, a semi-implantable hearing device for sensorineural hearing impairment. Otolaryngol Clin North Am 2001;34:373–388.
12.
Suzuki J, Kodera K, Yanagihara N: Middle ear implant for humans. Acta Otolaryngol 1985;99:313–317.
13.
Venail F, Lavieille JP, Meller R, Deveze A, Tardivet L, Magnan J: New perspectives for middle ear implants: first results in otosclerosis with mixed hearing loss. Laryngoscope 2007;117:552–555.
14.
Wever EG, Lawrence M: The transmission properties of the middle ear. 1950. Ann Otol Rhinol Laryngol 1992;101:191–204.
15.
Zenner HP, Limberger A, Baumann JW, Reischl G, Zalaman IM, Mauz PS, Sweetow RW, Plinkert PK, Zimmermann R, Baumann I, De Maddalena H, Leysieffer H, Maassen MM: Phase III results with a totally implantable piezoelectric middle ear implant: speech audiometry, spatial hearing and psychosocial adjustment. Acta Otolaryngol 2004;124:155–164.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.